
Please try another search
Despite the market volatility, shares in Tiziana Life Sciences (LON:TILS) have been in an uptrend in recent months. The question now for investors is whether that price strength will continue.
Finding stocks with the potential to break-out as their popularity grows is a strategy used by some of the world’s most successful traders.
Knowing what drives relative strength in share prices can help you find profitable momentum trades...
In terms of relative price strength the stock has performed well against the market over the past year:
This is important because relative strength is a useful tool in the armoury of technical traders and investors. It’s an instant measure of how a stock has performed in comparison with a benchmark.
And while there are no certainties about which way a stock will move next, research shows that price trends like this can persist.
Studies by leading experts on momentum show that stocks with the strongest price strength can keep up the pace for anywhere up to one year, as investors increasingly buy into them.
Tiziana Life Sciences is currently among the stocks with the strongest six-month and one-year relative price strength in the market. But momentum on its own is no guarantee of future returns.
To get a better idea about whether this momentum will continue, it's worth doing some investigation yourself.
Disclaimer: These articles are provided for information purposes only. The content is not intended to be a personal recommendation. The investments referred to in this article may not be suitable for all investors, and if in doubt, an investor should seek advice from a qualified investment adviser. The author has no position in the stocks mentioned, unless otherwise stated.
It was news a few days ago that Snap Inc (NYSE:SNAP), a social networking technology company, lost 45% in a single stock market session. This followed a profit warning from the...
Broad markets may have posted a relief rally yesterday after the FOMC meeting minutes showed that policymakers are considering the possibility of pausing the Fed's rate-hike cycle...
Deutsche Beteiligungs (ETR:DBANn) reported a 5.3% NAV decrease to €631.6m (defined as equity value) in H122 in total return terms. The main driver of the decrease was the...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.